MIACALCIN Trademark

Trademark Overview

On Friday, March 13, 1992, a trademark application was filed for MIACALCIN with the United States Patent and Trademark Office. The USPTO has given the MIACALCIN trademark a serial number of 74255027. The federal status of this trademark filing is REGISTERED AND RENEWED as of Tuesday, May 10, 2022. This trademark is owned by SANDOZ PHARMACEUTICALS CORPORATION. The MIACALCIN trademark is filed in the Pharmaceutical Products category with the following description:

pharmaceuticals used for the treatment of Paget's disease, osteoporosis and hypercalcemia
miacalcin

General Information

Serial Number74255027
Word MarkMIACALCIN
Filing DateFriday, March 13, 1992
Status800 - REGISTERED AND RENEWED
Status DateTuesday, May 10, 2022
Registration Number1726984
Registration DateTuesday, October 27, 1992
Mark Drawing1000 - Typeset: Word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, August 4, 1992

Trademark Statements

Goods and Servicespharmaceuticals used for the treatment of Paget's disease, osteoporosis and hypercalcemia

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes018
Class Status Code6 - Active
Class Status DateWednesday, April 22, 1992
Primary Code005
First Use Anywhere DateFriday, June 29, 1984
First Use In Commerce DateFriday, June 29, 1984

Trademark Owner History

Party NameNOVARTIS AG
Party Type41 - New Owner After Registration
Legal Entity Type03 - Corporation
AddressBasel 4002
CH
Party NameSANDOZ AG (SANDOZ LTS., SANDOZ S.A.)
Party Type40 - New Owner After Registration
Legal Entity Type03 - Corporation
AddressCH-4002 Basle
CH
Party NameSANDOZ PHARMACEUTICALS CORPORATION
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressE. Hanover, NJ 07936
Party NameSANDOZ PHARMACEUTICALS CORPORATION
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressE. Hanover, NJ 07936
Party NameSANDOZ PHARMACEUTICALS CORPORATION
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressE. Hanover, NJ 07936

Trademark Events

Event DateEvent Description
Tuesday, May 10, 2022NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
Tuesday, May 10, 2022REGISTERED AND RENEWED (THIRD RENEWAL - 10 YRS)
Tuesday, May 10, 2022REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
Tuesday, May 10, 2022CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Monday, January 10, 2022TEAS SECTION 8 & 9 RECEIVED
Wednesday, October 27, 2021COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Friday, December 7, 2012NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
Friday, December 7, 2012REGISTERED AND RENEWED (SECOND RENEWAL - 10 YRS)
Friday, December 7, 2012REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
Friday, December 7, 2012CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Monday, November 12, 2012TEAS SECTION 8 & 9 RECEIVED
Wednesday, March 3, 2010REVIEW OF CORRESPONDENCE COMPLETE
Tuesday, March 2, 2010CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Wednesday, June 17, 2009TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, March 13, 2008CASE FILE IN TICRS
Tuesday, December 28, 2004TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, December 17, 2004PAPER RECEIVED
Sunday, March 9, 2003REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
Sunday, March 9, 2003REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
Tuesday, November 26, 2002REGISTERED - COMBINED SECTION 8 (10-YR) & SEC. 9 FILED
Tuesday, November 26, 2002REGISTERED - COMBINED SECTION 8 (10-YR) & SEC. 9 FILED
Tuesday, November 26, 2002TEAS SECTION 8 & 9 RECEIVED
Friday, March 12, 1999REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Tuesday, October 27, 1998REGISTERED - SEC. 8 (6-YR) & SEC. 15 FILED
Tuesday, October 27, 1992REGISTERED-PRINCIPAL REGISTER
Tuesday, August 4, 1992PUBLISHED FOR OPPOSITION
Thursday, July 2, 1992NOTICE OF PUBLICATION
Thursday, May 14, 1992APPROVED FOR PUB - PRINCIPAL REGISTER

Related Keywords

miacalcin osteoporosis hypercalcemia disease paget used treatment pharmaceuticals